These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4778728)

  • 1. A multi-centre pilot study of tri-potassium di-citrato bismuthate ('De-Nol') in general practice.
    Cruickshank GW; Wright T
    Curr Med Res Opin; 1973; 1(10):629-34. PubMed ID: 4778728
    [No Abstract]   [Full Text] [Related]  

  • 2. Tri-potassium di-citrato bismuthate: a report of its pharmacological properties and therapeutic efficacy in peptic ulcer.
    Brogden RN; Pinder RM; Sawyer PR; Speight TM; Avery GS
    Drugs; 1976 Dec; 12(6):401-11. PubMed ID: 1001219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of tri-potassium di-citrato bismuthate (De-Nol) on the healing of chronic duodenal ulcers.
    Coughlin GP; Kupa A; Alp MH
    Med J Aust; 1977 Feb; 1(9):294-8. PubMed ID: 323663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind study of tri-potassium di-citrato bismuthate in doudenal ulcer.
    Shreeve DR
    Postgrad Med J; 1975; 51(5 Suppl):33-6. PubMed ID: 781653
    [No Abstract]   [Full Text] [Related]  

  • 5. De-Nol for gastric and duodenal ulcers.
    Drug Ther Bull; 1972 Nov; 10(24):95-6. PubMed ID: 4656484
    [No Abstract]   [Full Text] [Related]  

  • 6. Present and future treatment of peptic ulcer and potential role of DE-NOL.
    Scand J Gastroenterol Suppl; 1982; 80():49-57. PubMed ID: 6761852
    [No Abstract]   [Full Text] [Related]  

  • 7. Colloidal bismuth subcitrate in peptic ulcer disease.
    Tytgat GN
    S Afr Med J; 1986 Jul; 70(1):31-3. PubMed ID: 3523793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind trial of cimetidine versus tri-potassium di-citrato bismuthate in chronic duodenal ulceration.
    Ward M; Pollard EJ; Cowen A
    Med J Aust; 1981 Apr; 1(7):363-4. PubMed ID: 7017361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of cimetidine and tri-potassium di-citrato bismuthate (De-Nol) in chronic gastric ulceration: a comparative study.
    Tanner AR; Cowlishaw JL; Cowen AE; Ward M
    Med J Aust; 1979 Jan; 1(1):1-2. PubMed ID: 763184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double blind evaluation of the effect of tri-potassium di-citrato bismuthate in peptic ulcer.
    Poulantzas J; Polymeropoulos PS; Papasomatious A
    Br J Clin Pract; 1978 May; 32(5):147-8. PubMed ID: 352384
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: Effective treatment of gastric ulceration with a Bismuth preparation (De-Nol).
    Boyes BE; Woolf IL; Wilson RY; Cowley DJ; Dymock IW
    Gut; 1974 Oct; 15(10):833. PubMed ID: 4611754
    [No Abstract]   [Full Text] [Related]  

  • 12. [Characteristics of the effects of de-nol on the course of erosive-ulcerative lesions of the esophagus, stomach and duodenum associated with Helicobacter pylori].
    Grebenev AL; Miagkova LP; Golochevskaia VS; Lapina TL; Sklianskaia OA
    Klin Med (Mosk); 1995; 73(2):34-7. PubMed ID: 7609414
    [No Abstract]   [Full Text] [Related]  

  • 13. Tri-potassium di citrato bismuthate chewing tablets and cimetidine tablets in the treatment of duodenal ulcers. A double-blind double-dummy comparative study.
    Moshal MG; Spitaels JM; Khan F
    S Afr Med J; 1981 Sep; 60(11):420-3. PubMed ID: 7025264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical trial of sulpiride in ulcer diseases].
    Girard M; Sambin P; Trepo C
    Sem Hop; 1970 Feb; 46(8):511-6. PubMed ID: 4191877
    [No Abstract]   [Full Text] [Related]  

  • 15. [Tripotassium dicitrato bismuthate in the therapy of peptic ulcer: comparison with ranitidine in short-term treatment].
    Capurso L; Tarquini M; Luzietti L; Palomba M; Bazuro G; Papi C; Fracasso P; Koch M
    Clin Ter; 1984 May; 109(4):335-44. PubMed ID: 6088161
    [No Abstract]   [Full Text] [Related]  

  • 16. Caved-S and Ulcedal for peptic ulcer.
    Drug Ther Bull; 1973 Feb; 11(3):10-2. PubMed ID: 4571693
    [No Abstract]   [Full Text] [Related]  

  • 17. [Indications for sulpiride in gastroenterological therapy. Personal experience].
    Crismer R
    Brux Med; 1972 Dec; 52(12):861-70. PubMed ID: 4541098
    [No Abstract]   [Full Text] [Related]  

  • 18. Double blind randomised study of tripotassium-di-citrato-bismuthate in the treatment of peptic ulcer.
    Tripathi BM; Misra NP; Dube S
    J Assoc Physicians India; 1984 Nov; 32(11):964-5. PubMed ID: 6396295
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of tri-potassium di-citrato bismuthate tablets with ranitidine in healing and relapse of duodenal ulcers.
    Lee FI; Samloff IM; Hardman M
    Lancet; 1985 Jun; 1(8441):1299-302. PubMed ID: 2860494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental clinical study with agel-bismuth in the treatment of gastroduodenal lesions].
    Güemes Díaz F; Conesa Picó O; Hidalgo H; Arias Vallejo E
    Rev Esp Enferm Apar Dig; 1973 Dec; 41(7):841-52. PubMed ID: 4775610
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.